Predictors of cannabis use in men with and without psychosis

Addictive Behaviors

Volumn 32, Issue 12, 2007, Pages 2879-2887

  Green, Bob ^a   Kavanagh, David J ^b   Young, Ross McD ^c  

^a QUEENSLAND FORENSIC MENTAL HEALTH SERVICE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Cannabis; Expectancies; Prediction; Psychosis; Schizophrenia

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CANNABIS ADDICTION; DEMOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PSYCHOLOGICAL ASPECT; PSYCHOSIS; SUBSTANCE ABUSE;

ADULT; ANALYSIS OF VARIANCE; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; RISK FACTORS;

EID: 34648840275     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2007.04.024     Document Type: Article

References (33)

1. Arseneault L., Cannon M., Witton J., and Murray R. Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry 184 (2004) 110-117
2. Bandura A. Social foundations of thought and action: A social cognitive theory (1986), Prentice-Hall, Englewood Cliffs
3. Bennett M.E., Bellack A.S., and Gearon J.S. Development of a comprehensive measure to assess clinical issues in dual diagnosis patients: The Substance Use Event Survey for Severe Mental Illness. Addictive Behaviors 31 (2006) 2249-2267
4. California Department of Mental Health. Scoring manual for the California Quality of Life (CA-QOL) (1999), California Department of Mental Health, Sacramento
5. D'Souza D.C., Abi-Saab W.M., Madonick S., Forselius-Bielen K., Doersch A., Braley G., et al. Delta-9-tetrahydrocannabinol effects on schizophrenia: Implications for cognition, psychosis, and addiction. Biological Psychiatry 57 (2005) 594-608
6. D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu T., et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology 29 (2004) 1-15
7. Dixon L., Haas G., Wieden P.J., Sweeney J., and Frances A.J. Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. American Journal of Psychiatry 148 (1991) 224-230
8. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., and Rutigliano P. The Timeline Followback reports of psychoactive substance abuse by drug-abusing patients: Psychometric properties. Journal of Consulting and Clinical Psychology 68 (2000) 134-144
9. Goldman M.S., and Darkes J. Alcohol expectancy multiaxial assessment: A memory network-based approach. Psychological Assessment 16 (2004) 4-15
10. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., et al. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90 (1995) 607-614
11. Goswami S., Mattoo S.K., Basu D., and Singh G. Substance-abusing schizophrenics: Do they self-medicate?. The American Journal on Addictions 161 (2004) 1231-1237
12. Green B., Kavanagh D., and Young R. On being stoned: The self-reported effects of cannabis. Drug and Alcohol Review 22 (2003) 453-460
13. Green B., Kavanagh D.J., and Young R.M. Reasons for cannabis use in men with and without psychosis. Drug and Alcohol Review 23 (2004) 445-453
14. Green B., Young R.M., and Kavanagh D. Cannabis use and misuse prevalence among people with psychosis. British Journal of Psychiatry 187 (2005) 306-313
15. Hathaway A.D. Cannabis effects and dependency concerns in long term frequent users: A missing piece of the public health puzzle. Addiction Research and Theory 11 (2003) 441-458
16. Hides L., Dawe S., Kavanagh D.J., and Young R.M. A prospective study of psychotic symptom and cannabis relapse in recent onset psychosis. British Journal of Psychiatry 189 (2006) 137-143
17. Jablensky A., McGrath J., Herrman H., Castle D., Gureje O., Evans M., et al. Psychotic disorders in urban areas: An overview of the study on low prevalence disorders. Australian and New Zealand Journal of Psychiatry 34 (2000) 221-236
18. Jones R.T. Marihuana-induced "high": Influence of expectation, setting and previous drug experience. Pharmacological Reviews 23 (1971) 359-369
19. Jones B.T., Corbin W., and Fromme K. A review of expectancy theory and alcohol consumption. Addiction 96 (2001) 57-72
20. Kavanagh D.J., Andrade J., and May J. "The imaginary relish": A cognitive-emotional model of craving, desires and appetitive rumination. Psychological Review 112 (2005) 446-467
21. Kavanagh D.J., and Mueser K.T. Current evidence on integrated treatment for serious mental disorder and substance misuse. Journal of the Norwegian Psychological Association 44 (2007) 618-637
22. Kavanagh D.J., Saunders J.B., Young R., White A., Jenner L., Clair A., et al. Evaluation of screening and brief intervention for substance abuse in early psychosis (1999), AUSEINET, Adelaide
23. Kavanagh D.J., Young R., White A., Saunders J.B., Wallis J., Shockley N., et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review 23 (2004) 151-155
24. Leigh B.C., and Stacy A.W. On the scope of alcohol expectancy research: Remaining issues of measurement and meaning. Psychological Bulletin 110 (1991) 147-154
25. Mueser K.T., Drake R.E., and Wallach M.A. Dual diagnosis: A review of etiological theories. Addictive Behaviors 23 (1998) 717-734
26. Perneger T.V. What's wrong with Bonferroni adjustments. British Medical Journal 316 (1998) 1236-1238
27. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association 264 (1990) 2511-2518
28. Rössler W., Saliz H.J., van Os J., and Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. European Neuropsychopharmacology 15 (2005) 399-409
29. Saunders J.B., Aasland O.G., Babor T.F., De La Fuente J.R., and Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction 88 (1993) 791-804
30. Sobell L.C., and Sobell M.B. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In: Litten R.Z., and Allen J. (Eds). Measuring alcohol consumption: psychosocial and biological methods (1992), Humana Press, New Jersey 41-72
31. Spencer C., Castle D., and Michie P. Motivations that maintain substance use among individuals with psychotic disorders. Schizophrenia Bulletin 28 (2002) 233-247
32. Swartz M.S., Swanson J.W., and Hannon M.J. Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair. Psychiatric Services 54 (2003) 891-895
33. Swift W., Copeland J., and Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 93 (1998) 1681-1692